Biopharmaceutical Analysis & Statistics, January 2013 (p20)

Guatemala Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Guatemala

Croatia Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Croatia

Ireland Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Ireland

India Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : India

Egypt Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Egypt

Brazil Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Brazil

Czech Republic Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Czech Republic

Colombia Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Colombia

Canada Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Canada

Argentina Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Biopharmaceutical
Countries : Argentina

XTL Biopharmaceuticals Ltd.-Detailed Product Pipeline

$ 750
Company report
March 2011
by Life Science Analytics (LSA)

XTL Biopharmaceuticals Ltd.-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information and detailed ...

Industries : Biopharmaceutical
Countries : World

OMRIX biopharmaceuticals LTD-Therapeutic Competitors Report

$ 350
Company report
March 2011
by Life Science Analytics (LSA)

OMRIX biopharmaceuticals LTD-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company ...

Industries : Biopharmaceutical

Response Biomedical Corporation-Deals & Alliances Report

$ 600
Company report
March 2011
by Life Science Analytics (LSA)

Response Biomedical Corporation-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by deal ...

Industries : Biopharmaceutical

Analysis of the Southeast Asian Animal Feed Ingredients Market

$ 6 000
Industry report
March 2011
by Frost & Sullivan

This research investigates the state of the Southeast Asian animal feed ingredients market in 2010. The historical period is from 2007 to 2009, and forecasts are provided until 2017. The study clearly ...

Industries : Livestock, Biopharmaceutical
Countries : Asia

Medical Enzymes: Technologies and Global Markets

$ 5 450
Industry report
March 2011
by BCC Research

The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach ...

Industries : Biopharmaceutical
Countries : World

Monoclonal Antibodies: A Segment of Major Growth

$ 3 195
Industry report
March 2011
by CHI Insight Pharma Reports

Monoclonal antibodies are highly valuable therapeutic agents and were among the best-selling drugs in the world in 2010. Global revenues from monoclonal antibody products will have moved significantly ...

Industries : Biopharmaceutical
Countries : United States

Chinese Markets for Enzymes

$ 2 000
Industry report
March 2011
by Asia Market Information & Development Company

China's demand for enzymes has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment ...

Industries : Biopharmaceutical
Countries : China

Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011

$ 2 214
Company report
February 2011
by BioPharm Reports

The breast cancer immunotherapy pipeline is showing rapid development. This report presents findings on more than 30 candidate therapies, including 22 therapeutic vaccines and 11 antibodies. Of the 22 ...

Industries : Biopharmaceutical

Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011

$ 2 206
Company report
February 2011
by BioPharm Reports

The prostate cancer immunotherapy pipeline is showing rapid development. Currently, there are 30 candidates in the pipeline (16 vaccines and 14 therapeutic antibodies), and one prostate cancer vaccine ...

Industries : Biopharmaceutical

Analysis of Nabi Biopharmaceuticals

$ 200
Company report
February 2011
by Aruvian's R'search

Aruvian's R'search presents Analysis of Nabi Biopharmaceuticals. A complete and comprehensive analysis of Nabi Biopharmaceuticals, includes an overview of the industry the company operates in, a PEST Framework ...

Industries : Biopharmaceutical

Nabi Biopharmaceuticals - SWOT Framework Analysis

$ 95
Company report
February 2011
by Aruvian's R'search

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of ...

Industries : Biopharmaceutical

Omrix Biopharmaceuticals, Inc. - SWOT Framework Analysis

$ 95
Company report
February 2011
by Aruvian's R'search

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of ...

Industries : Biopharmaceutical

Competitor Analysis Therapeutic Proteins: Biosimilars, Biobetters and Biosuperiors

$ 2 051
Industry report
February 2011
by La Merie Publishing

Overview Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors The Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors as of February 2011 provides a ...

Industries : Biopharmaceutical

Danisco A/S SWOT

$ 175
Company report
February 2011
by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Danisco is engaged in the development, production ...

Industries : Biopharmaceutical
Countries : Denmark

Competitor Analysis Cancer Antibodies in Early Clinical Develoment

$ 1 161
Industry report
February 2011
by La Merie Publishing

Product description The present Competitive Intelligence Report about Cancer Antibodies in Early Clinical Development provides a competitor evaluation in the field of antibody therapeutics being developed ...

Industries : Biopharmaceutical
Countries : United States

Enzymes in Industrial Applications: Global Markets

$ 5 450
Industry report
January 2011
by BCC Research

The global market for industrial enzymes is estimated at $3.3 billion in 2010. This market is expected to reach $4.4 billion by 2015, a compound annual growth rate (CAGR) of 6% over the 5-year forecast ...

Industries : Biopharmaceutical
Countries : World

Competitor Analysis Erythropoietin (EPO)

$ 645
Industry report
January 2011
by La Merie Publishing

Product description The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second ...

Industries : Biopharmaceutical
Countries : India, World, Mexico, China

Competitor Analysis Human Growth Hormone (hGH)

$ 452
Industry report
January 2011
by La Merie Publishing

Product description The Competitive Intelligence Report Human Growth Hormone (hGH) as of January 2011 provides a competitor analysis in the development pipeline of biosimilar (biogeneric) versions of somatropin ...

Industries : Biopharmaceutical

Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

This report provides data on the therapeutic development for Growth Hormone Deficiency , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

Industries : Biopharmaceutical
Countries : World, United States

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

$ 3 500
Industry report
December 2010
by GBI Research

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions Summary GBI Research, the leading business intelligence provider, has released its latest ...

Industries : Biopharmaceutical
Countries : World, United States, Japan, Europe

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

Industries : Biopharmaceutical
Countries : United States, World

Biopharmaceutical in United States: Inovio Pharmaceuticals, Inc. ? Product Pipeline Review - Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

Industries : Biopharmaceutical
Countries : United States

InNexus Biotechnology Inc. SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
December 2010
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical
Countries : Canada, United States, United Kingdom

Medarex, Inc.: SWOT Analysis & Company Profile

$ 99
Company report
December 2010
by Business Review

Synopsis Business Review's Medarex, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company ...

Industries : Biopharmaceutical

U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016)

$ 4 650
Industry report
December 2010
by MarketsandMarkets

Report Description This research report analyzes the U.S. biopharmaceuticals market and its growth factors, with special emphasis on the top companies in the field and their product pipeline. While it ...

Industries : Biopharmaceutical
Countries : United States

Indian Industrial Enzymes Market

$ 6 000
Industry report
November 2010
by Frost & Sullivan

This research investigates the Indian industrial enzymes market from 2006 to 2009, with forecasts to 2015. It offers a comprehensive insight to the Indian industrial enzymes market, its structure and developments ...

Industries : Biopharmaceutical
Countries : India

Pharmaceutical Stability Testing: Commercial Prospects 2011-2025

$ 2 411
Industry report
November 2010
by Visiongain

Where you can find the opportunities there How will the pharma stability testing sector develop from 2010, and where can you find the greatest opportunities there? How will technology suppliers and drug ...

Industries : Biopharmaceutical
Countries : World

A Decision Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market

$ 2 824
Industry report
November 2010
by Bioseeker

This report comprises defined and up to date development strategies for 218 melanoma drugs within the portfolio of 138 companies, from Ceased to Marketed. The report extensively analyses their 170 identified ...

Industries : Biopharmaceutical, Drug Discovery and Development, Biotechnology

ImmunoGen, Inc.: SWOT Analysis & Company Profile

$ 99
Company report
November 2010
by Business Review

Synopsis Business Review's ImmunoGen, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company ...

Industries : Biopharmaceutical
Countries : United States

Biopharmaceutical Industry: Keryx Biopharmaceuticals - Product Pipeline Review - Q4 2010

$ 500
Company report
November 2010
by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the firm ?s future therapy ...

Industries : Biopharmaceutical
Countries : World